1-9244919-CCCCAGGCA-C
Position:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 4P and 16B. PVS1_StrongBP6_Very_StrongBA1
The NM_004285.4(H6PD):c.-7_1del variant causes a splice acceptor, 5 prime UTR, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.144 in 1,609,272 control chromosomes in the GnomAD database, including 18,758 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.12 ( 1493 hom., cov: 30)
Exomes 𝑓: 0.15 ( 17265 hom. )
Consequence
H6PD
NM_004285.4 splice_acceptor, 5_prime_UTR, intron
NM_004285.4 splice_acceptor, 5_prime_UTR, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.77
Genes affected
H6PD (HGNC:4795): (hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase) There are 2 forms of glucose-6-phosphate dehydrogenase. G form is X-linked and H form, encoded by this gene, is autosomally linked. This H form shows activity with other hexose-6-phosphates, especially galactose-6-phosphate, whereas the G form is specific for glucose-6-phosphate. Both forms are present in most tissues, but H form is not found in red cells. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
PVS1
Splicing +-2 bp (donor or acceptor) variant, product NOT destroyed by NMD, known LOF gene, truncates exone, which is 0.26767677 fraction of the gene. Cryptic splice site detected, with MaxEntScore 8.7, offset of 0 (no position change), new splice context is: tgtctctctttgcaccccAGgca. Cryptic site results in inframe change. If cryptic site found is not functional and variant results in exon loss, it results in frameshift change.
BP6
Variant 1-9244919-CCCCAGGCA-C is Benign according to our data. Variant chr1-9244919-CCCCAGGCA-C is described in ClinVar as [Benign]. Clinvar id is 402919.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-9244919-CCCCAGGCA-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.208 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
H6PD | NM_004285.4 | c.-7_1del | splice_acceptor_variant, 5_prime_UTR_variant, intron_variant | 2/5 | ENST00000377403.7 | NP_004276.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
H6PD | ENST00000377403.7 | c.-7_1del | splice_acceptor_variant, 5_prime_UTR_variant, intron_variant | 2/5 | 1 | NM_004285.4 | ENSP00000366620 | P1 | ||
H6PD | ENST00000602477.1 | c.27_34del | p.Pro10ValfsTer38 | splice_acceptor_variant, coding_sequence_variant, intron_variant | 2/5 | 1 | ENSP00000473348 |
Frequencies
GnomAD3 genomes AF: 0.123 AC: 18716AN: 152034Hom.: 1484 Cov.: 30
GnomAD3 genomes
AF:
AC:
18716
AN:
152034
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.159 AC: 39376AN: 247588Hom.: 3814 AF XY: 0.154 AC XY: 20680AN XY: 133960
GnomAD3 exomes
AF:
AC:
39376
AN:
247588
Hom.:
AF XY:
AC XY:
20680
AN XY:
133960
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.146 AC: 213384AN: 1457120Hom.: 17265 AF XY: 0.147 AC XY: 106572AN XY: 725118
GnomAD4 exome
AF:
AC:
213384
AN:
1457120
Hom.:
AF XY:
AC XY:
106572
AN XY:
725118
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.123 AC: 18744AN: 152152Hom.: 1493 Cov.: 30 AF XY: 0.128 AC XY: 9535AN XY: 74380
GnomAD4 genome
AF:
AC:
18744
AN:
152152
Hom.:
Cov.:
30
AF XY:
AC XY:
9535
AN XY:
74380
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
424
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency in 1000Genomes: 255/2178= 11.71% - |
Cortisone reductase deficiency 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Apr 11, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.